The Analysis of Factors Influencing the Vd of Imipenem in Septic Shock Patients
NCT03308214 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2021-01-05
Summary
The study measures the plasma concentrations of imipenem in septic shock patients and non-septic shock patients and observes hypoalbuminemia and the impact of the severity of critical illness on Vd
Conditions
- Septic Shock
Interventions
- DRUG
-
Imipenem
Imipenem 1.0 q 8h
Sponsors & Collaborators
-
Southeast University, China
lead OTHER
Principal Investigators
-
Songqiao Liu, PHD · Study Investigator
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-18
- Primary Completion
- 2018-12-28
- Completion
- 2018-12-28
Countries
- China
Study Locations
More Related Trials
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
White Blood Cells and Platelets Indices as a Prognostic Factor in Neonatal Sepsis
NCT03880305 ·Status: UNKNOWN
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Pharmacokinetics of XueBiJing in Patients With Sepsis
NCT03475732 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department
NCT02365272 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients With Septic Shock
NCT03158948 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis
NCT05190861 ·Status: COMPLETED ·Phase: NA
-
Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis
NCT02898961 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock
NCT04948372 ·Status: COMPLETED ·Phase: NA
-
Anisodamine Critically Ill SeptIc Shock
NCT02442440 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
NeoAMR Observational Study in Neonatal Sepsis
NCT03721302 ·Status: COMPLETED
-
Methylene Blue for the Treatment of Septic Shock
NCT06532240 ·Status: COMPLETED ·Phase: PHASE3
-
mNGS vs Culture Critically Ill Patients
NCT03760315 ·Status: UNKNOWN
-
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
NCT03344627 ·Status: COMPLETED ·Phase: NA
-
N\L Ratio Versus L\A Ratio as a Predictor of Morbidity and Mortality in Sepsis and Septic Shock
NCT05825118 ·Status: UNKNOWN
-
Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient
NCT03153306 ·Status: UNKNOWN ·Phase: PHASE4
-
Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis
NCT04973670 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS
NCT06063707 ·Status: NOT_YET_RECRUITING
-
Early Goal Directed Sedation on Microcirculation in Septic Shock
NCT02612363 ·Status: UNKNOWN ·Phase: PHASE4
-
Dex on Microcirculation in SS-A Double-blinded Study
NCT02612181 ·Status: UNKNOWN ·Phase: PHASE4
-
The Clinical and Pharmacoeconomic Impact of Rapid Diagnostic Test (Multiplex PCR FilmArray) on Antimicrobial Decision Making Compared to Conventional Decision Making Among Critically Ill Patients
NCT05759494 ·Status: UNKNOWN
-
Hypophosphatemia Deleteriously Affects Outcome of Septic Shock Patients Admitted to ICU
NCT04455113 ·Status: COMPLETED
-
Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.
NCT02300415 ·Status: UNKNOWN
-
Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events
NCT05502107 ·Status: COMPLETED ·Phase: NA